Sequential phenotype changes in progressive lesions of breast carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Pathology

Background:

• Malignant transformation involves genetic events leading to cellular growth and cell cycle dysregulation.
• Breast cancer progression is characterized by the acquisition of multiple genetic abnormalities.

Purpose of the Study:

• To correlate the expression of estrogen receptor (ER), progesterone receptor (PR), c-erbB-2, and p53 with histological features in a mixed invasive breast carcinoma.
• To understand the role of these molecular markers in the multistep process of breast tumorigenesis.

Main Methods:

• Immunohistochemical analysis of ER, PR, c-erbB-2, and p53 expression.
• Evaluation of coexisting lesions within a single patient's breast tumor sample.

Main Results:

• Estrogen receptor (ER) positivity was absent. Progesterone receptor (PR) expression was limited to normal epithelium, hyperplasia, and in situ carcinoma.
• c-erbB-2 was detected in all lesions except normal epithelium. p53 positivity was observed only in in situ and invasive carcinoma.
• Loss of hormone receptor expression appeared to be an early event, while p53 mutations were associated with advanced neoplastic lesions.

Conclusions:

• Tumorigenesis is a multistep process involving sequential acquisition of molecular changes.
• Hormone receptor loss is an early event in breast cancer development, whereas p53 alterations occur in later stages.
• The distinct expression patterns of these markers support their roles in different phases of breast cancer progression.